These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

75 related items for PubMed ID: 21658150

  • 21. Cardiovascular risk screening before starting stimulant medications and prescribing practices of canadian physicians: impact of the Health Canada advisory.
    Conway J, Wong KK, O'Connell C, Warren AE.
    Pediatrics; 2008 Oct; 122(4):e828-34. PubMed ID: 18829780
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Stimulant treatment and injury among children with attention deficit hyperactivity disorder: an application of the self-controlled case series study design.
    Raman SR, Marshall SW, Haynes K, Gaynes BN, Naftel AJ, Stürmer T.
    Inj Prev; 2013 Jun; 19(3):164-70. PubMed ID: 23143347
    [Abstract] [Full Text] [Related]

  • 24. Moderators and mediators of long-term adherence to stimulant treatment in children with ADHD.
    Thiruchelvam D, Charach A, Schachar RJ.
    J Am Acad Child Adolesc Psychiatry; 2001 Aug; 40(8):922-8. PubMed ID: 11501692
    [Abstract] [Full Text] [Related]

  • 25. [Prescribing ritalin in combined modality management of hyperactivity with attention deficit].
    Bricard C, Boidein F.
    Encephale; 2001 Aug; 27(5):435-43. PubMed ID: 11760693
    [Abstract] [Full Text] [Related]

  • 26. Pharmacologic treatment of attention-deficit/hyperactivity disorder in children: incidence, prevalence, and treatment patterns in the Netherlands.
    Hodgkins P, Sasané R, Meijer WM.
    Clin Ther; 2011 Feb; 33(2):188-203. PubMed ID: 21497704
    [Abstract] [Full Text] [Related]

  • 27. Prevalence of methylphenidate prescription among school-aged children in a Swiss population: increase in the number of prescriptions in the Swiss Canton of Vaud, from 2002 to 2005, and changes in patient demographics.
    Gumy C, Huissoud T, Dubois-Arber F.
    J Atten Disord; 2010 Nov; 14(3):267-72. PubMed ID: 20484708
    [Abstract] [Full Text] [Related]

  • 28. Parents report on stimulant-treated children in the Netherlands: initiation of treatment and follow-up care.
    Faber A, Kalverdijk LJ, de Jong-van den Berg LT, Hugtenburg JG, Minderaa RB, Tobi H.
    J Child Adolesc Psychopharmacol; 2006 Aug; 16(4):432-40. PubMed ID: 16958568
    [Abstract] [Full Text] [Related]

  • 29. Prescribed stimulant use by Western Australians with Attention Deficit Hyperactivity Disorder (ADHD): does amount dispensed exceed the expected authorised use?
    Calver J, Sanfilippo F, Preen D, Bulsara M.
    Aust N Z J Public Health; 2007 Dec; 31(6):533-9. PubMed ID: 18081573
    [Abstract] [Full Text] [Related]

  • 30. [A pilot study of methylphenidate and parent training in the treatment of children with attention-deficit hiperactivity disorder].
    Montiel Nava C, Peña JA, Espina Mariñes G, Ferrer-Hernandez ME, López-Rubio A, Puertas-Sánchez S, Cardozo-Durán JJ.
    Rev Neurol; 2007 Dec; 35(3):201-5. PubMed ID: 12235578
    [Abstract] [Full Text] [Related]

  • 31. Drugged-out toddlers. A new study documents an alarming increase in behavior-altering medication for preschoolers.
    Kalb C.
    Newsweek; 2000 Mar 06; 135(10):53. PubMed ID: 10847892
    [No Abstract] [Full Text] [Related]

  • 32. Acute tolerance to methylphenidate in the treatment of attention deficit hyperactivity disorder in children.
    Swanson J, Gupta S, Guinta D, Flynn D, Agler D, Lerner M, Williams L, Shoulson I, Wigal S.
    Clin Pharmacol Ther; 1999 Sep 06; 66(3):295-305. PubMed ID: 10511066
    [Abstract] [Full Text] [Related]

  • 33. Cardiac safety of central nervous system stimulants in children and adolescents with attention-deficit/hyperactivity disorder.
    Winterstein AG, Gerhard T, Shuster J, Johnson M, Zito JM, Saidi A.
    Pediatrics; 2007 Dec 06; 120(6):e1494-501. PubMed ID: 18055666
    [Abstract] [Full Text] [Related]

  • 34. Patterns of psychostimulant prescribing to children with ADHD in Western Australia: variations in age, gender, medication type and dose prescribed.
    Preen DB, Calver J, Sanfilippo FM, Bulsara M, Holman CD.
    Aust N Z J Public Health; 2007 Apr 06; 31(2):120-6. PubMed ID: 17461001
    [Abstract] [Full Text] [Related]

  • 35. [Hyperactivity and prescription of Ritalin in the canton of Vaud (Switzerland), 2002].
    Huissoud T, Jeannin A, Dubois-Arber F.
    Rev Epidemiol Sante Publique; 2007 Oct 06; 55(5):357-63. PubMed ID: 17889474
    [Abstract] [Full Text] [Related]

  • 36. [Stimulant therapy in children].
    Steinhausen HC.
    Pharmacopsychiatria; 1982 Nov 06; 15(6):181-2. PubMed ID: 6130534
    [No Abstract] [Full Text] [Related]

  • 37. Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database.
    Winterstein AG, Gerhard T, Shuster J, Zito J, Johnson M, Liu H, Saidi A.
    Ann Pharmacother; 2008 Jan 06; 42(1):24-31. PubMed ID: 18042808
    [Abstract] [Full Text] [Related]

  • 38. Paediatricians' decision making about prescribing stimulant medications for children with attention-deficit/hyperactivity disorder.
    Chow SJ, Sciberras E, Gillam LH, Green J, Efron D.
    Child Care Health Dev; 2014 May 06; 40(3):301-8. PubMed ID: 23445484
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.